Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Jack Rubin, MD

Medical Director
Davita Los Angeles Dialysis Center
Member of the Healthcare Council

Jack Rubin, MD, is Medical Director of the Los Angeles Vascular Access Center (LAVAC) in Inglewood, California. LAVAC does out patient procedures to correct problems with vascular accesses in dialysis patients. LAVAC also does out-patient angiograms of the legs and repairs stenoses of femoral arteries of the legs, in patients with Peripheral arterial disease, again as an out-paitent procedure. Dr. Rubin has also testified on the behalf of plaintiff and defendant in malpractice cases in California, Arizona and Puerto Rico. He is also a Chief Medical Examiner for the California Board of Medicine. Dr. Rubin has had experience in wound care and is an expert in non-healing wound of patients' be they due to decubitus uclers of peripheral arterial disease. (This is me - Update Profile)


Employment History
1998 - present Medical Director
Davita Los Angeles Dialysis Center
Unspecified - present Medical Director and Chief Executive Officer
Los Angeles Vascular Access Center

GLG Study Groups with Jack Rubin, MD(?)

View All Study Groups with Jack Rubin, MD

GLG NewsSM Analyses by Jack Rubin, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Tekturan losers blood pressure and proteinuria simultaneously | 05-27-2008
Analysis of: New data show Tekturna HCT® is twice as effective at reducing blood pressure than the diuretic HCT alone | www.novartis.com
Author: Jack Rubin, MD, Medical Director, Davita Los Angeles Dialysis Center

While no more would argue that control of systolic hypertension is crucial to preventing the consequences of hypertension such as congestive heart failure, MI's, left ventricular hyperthrophy, stroke and kidney failure there are other factors that are associated with these disease states. One of these...

sitaglitpin | 11-06-2006
Analysis of: MEDICARE ADDS PERFORMANCE-BASED PAYMENTS FOR PHYSICIANS | www.cms.hhs.gov
Author: Jack Rubin, MD, Medical Director, Davita Los Angeles Dialysis Center

This drug is from a new class of agents that treat type II diabetes. The advantages of this class of drugs is that there is no hypoglycemia nor is there weight gain on those patients being treated with them. 

GLG InstituteSM Seminars with Jack Rubin, MD(?)

 
Jack Rubin, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Jack Rubin, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-10-15T17:45:18.060